Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008 4/12/2025

184,18 USD (+0,86%)

(+0,86%) 4/12/2025

Grafiek Quest Diagnostics, Inc.

Grafiek Quest Diagnostics, Inc.

1 dag1d 0,86%
1 week1w 0,22%
1 maand1m 4,35%
3 maanden3m 0,90%
6 maanden6m 5,64%
1 jaar1j 17,05%
5 jaar5j 49,86%

Quest Diagnostics, Inc. in het nieuws

Toon enkel gratis nieuws

11 november 2025 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

3 november 2025 · Quest Diagnostics to Speak at Citi's 2025 Global Healthcare Conference · Persbericht

27 oktober 2025 · New Study Demonstrates Accuracy of Two Quest AD-Detect® Tests for Alzheimer's Disease Diagnosis · Persbericht

21 oktober 2025 · Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 · Persbericht

25 september 2025 · Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 · Persbericht

23 september 2025 · Quest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration · Persbericht

22 september 2025 · Haystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer · Persbericht

16 september 2025 · Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference · Persbericht

4 september 2025 · Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering · Persbericht

2 september 2025 · Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index · Persbericht

Profiel Quest Diagnostics, Inc.

Diensten aan de gezondheidssector

Gezondheidszorg

Tandheelkundige laboratoria

Website: www.questdiagnostics.com

Hoofdzetel: Secaucus, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe